Tobacco smoking and cardiovascular diseases;Consommation de tabac et risque cardiovasculaire

Revue de Medecine Interne

Volumn 18, Issue 9, 1997, Pages 702-708

  Veyssier Belot, C ^a  

^a HÔTEL DIEU   (France)

Author keywords

Atherosclerosis; Cardiovascular diseases; Cigarette smoking; Passive smoking

Indexed keywords

FIBRINOGEN; LIPID;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; FIBRINOLYSIS; HUMAN; PASSIVE SMOKING; REVIEW; RISK FACTOR; SMOKING CESSATION; THROMBOCYTE FUNCTION; TOBACCO;

EID: 0342546622     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)83749-6     Document Type: Article

References (63)

1. Peto R. Smoking and death: the past 40 years and the next 40. Br Med J 1994;309:937-9
2. Kannel WB, McGee DL, Castelli WP. Latest perspective on cigarette smoking and cardiovascular disease: the Framingham Study. J Cardiac Rehabil 1984;4:267-77
3. Escobedo LG, Zack MM. Comparison of sudden and non-sudden coronary deaths in the United States. Circulation 1996;93:2033-6
4. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurence of sudden cardiac arrest. N Engl J Med 1986;34:271-5
5. Rigotti NA, Eagle KA. Atrial fibrillation while chewing nicotine gum. JAMA 1986;255:1018
6. Latest perspective on cigarette smoking and cardiovascular disease among men in the Framingham Study. J Cardiac Rehabil 1984;4:267-77
7. Gottlieb S, Boyko V, Zahger D, Balkin J, Hod H, Felled B, Stem S, Behar S. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli thrombolytic national survey). J Am Coll Cardiol 1996;28:1506-13p
8. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313:1511-4
9. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med 1994; 154:169-75
10. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br Med J 1989;298:789-94
11. Giroud M, Dumas R. Rôle du tabac dans les accidents vasculaires cérébraux. Presse Méd 1994;23:1037-9
12. Schievink WI. Intracranial aneurysms. N Engl J Med 1997; 336:28-40
13. Moore WS, Barnett HJM, Beebe HG et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc committee, American Heart Association. Circulation 1995;91:566-79
14. Tell GS, Polak JF, Ward BJ, Kittner SJ, Savage PJ, Robbins J. Relation of smoking with carotid artery wall thickness and stenosis in older adults. The cardiovascular Health Study. Circulation 1994;90:2905-8
15. Gaetani P, Tartara F, Tancioni F, Klersy C, Forlino A, Baena RRY. Activity of alpha 1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm. J Neurol Sci 1996;141:33-8
16. Juvela S. Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Arch Neurol 1996;53:734-40
17. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269:232-6
18. Kannel WB, Shurtleff D. The Framingham study. Cigarettes smoking and the development of intermittent claudication. Geriatrics 1973:63-9
19. Thomas M. Smoking and vascular surgery. Br J Surg 1981; 68:601-4
20. Eneroth M, Persson BM. Risk factors for failed healing in amputation for vascular disease. A prospective consecutive study of 177 cases. Acta Orthop Scand 1993;64:369-72
21. Krupski WC, Complications vasculaires périphériques du tabagisme. Ann Chir Vasc 1991;5:291-304
22. Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med 1990;113:135-46
23. Coffman JD. Intermittent claudication. Be conservative. N Engl J Med 1991;325:577-8
24. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation in relation to total mortality rates in women. Ann Intern Med 1993;119:992-1000
25. LaCroix AZ, Lang J, Scherr P et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991;324:1619-25
26. Kritz H, Schmid P, Sinzinger H. Passive smoking and cardiovascular risk. Arch Int Med 1995;155:1942-8
27. Przyklenk K. Nicotine exacerbates postischemic contractile dysfunction of "stunned" myocardium in the canine model. Circulation 1994;89:1272-81
28. Zhu B, Sun Y, Sievers RE, Glantz SA, Parmley WW, Wolfe CL. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation 1994;89:1282-90
29. Mc Gill HC. Smoking and the pathogenesis of atherosclerosis. In: Diana JN, ed. Tobacco smoking and atherosclerosis. New York: Plenum press, 1990:9-16
30. Stary HC, Chandler AB, Glagov et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Special report. Arterioscl Thromb 1994;14:840-56
31. Fishbein MC, Siegel RJ. How big are coronary atherosclerotic plaques that rupture? Circulation 1996;94:2662-6
32. Hammoudeh AJ, Haft JI. Coronary-plaque rupture in acute coronary syndromes triggered by snow shoveling [Letter]. N Engl J Med 1996;335:2001
33. Shepperd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7
34. Scandinavian Simvastatin Survival Study group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study Group (4S). Lancet 1994;344:1383-9
35. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events. Br Heart J 1993;69(suppl):S48-S53
36. Moliterno DJ, Willard JE, Lange RA et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking or both. N Engl J Med 1994;330:454-9
37. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-7
38. Barry J, Mead K, Nabel EG et al. Effect of smoking on the activity of ischemic heart disease. JAMA 1989;261:398-402
39. Pepine CJ, Cohn PF, Deedwania PC et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90:762-8
40. Green MS, Jucha E, Luz Y. Blood pressure in smokers and non-smokers: Epidemiologic findings. Am Heart J 1986;111:932-40
41. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989;298:784-8
42. Tell GS, Polak JF, Ward BJ, Kittner SJ, Savage PJ, Robbins J. Relation of smoking wiht carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Study. Circulation 1994;90:2905-8
43. Kagota S, Yamaguchi Y, Shinozuka K, Kwon Y, Kunimoto M. Cigarette smoke-modified low density lipoprotein impairs endothelium-dependant relaxation in isolated rabbit arteries. Gen Pharma 1996;27:477-81
44. Eliasson B, Attvall S, Taskinen M, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Anterioscl Thromb 1994;14:1946-50
45. Eliasson B, Taskinen M, Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996;94:878-81
46. Juhan-Vague I. Haemostatic parameters and vascular risk. Atherosclerosis 1996;124(suppl):S49-S55
47. FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and haemostatic function. Am Heart J 1988;115:267-71
48. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-63
49. Nowak J, Murray JJ, Oates JA, Fitz, GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987;1:6-14
50. Sagone AL, Balcerzak SP. Smoking as a cause of erythrosis. Ann Intern Med 1975;82:512-5
51. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking and myocardial infarction. N Engl J Med 1981;304: 465-8
52. Dintenfass L. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels in cigarette smokers. Med J Austr 1975;1:617-9
53. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S. Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscl Thromb 1992;12:1305-12
54. Zeiher AM. Endothelial vasodilatator dysfunction:pathogenetic link to myocardial ischaemia or epiphenomenon? Lancet 1996;348(suppl):S10-2
55. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothélium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094-100
56. Mc Veigh GE, Lemay L, Morgan D, Cohn JN. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 1996;78:668-72
57. Ross R. The pathogenesis of atherosclerosis:a perspective for the 1990s. Nature 1993;362:801-9
58. Penn A, Chen LC, Snyder CA. Inhalation of steady-state sidestream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation 1994;90:1363-7
59. Aronow WS. Effect of passive smoking on angina pectoris. N Engl J Med 1978;299:21-4
60. Dobson AJ, Alexander HM, Heller RF, Lloyd DM. Passive smoking and the risk of heart attack or coronary death. Med J Austr 1991;154:793-7
61. Schmid P, Karanikas G, Kritz et al. Passive smoking and platelet thromboxane. Thromb Res 1996;81:451-60
62. Celermajer DS, Adams MR, Clarkson P et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-4
63. Renaud R, Lellouche D. La contraception orale œstroprogestative en 1987. Rev Prat 1987;38:2269-301